These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15497754)

  • 1. Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice.
    Hao X; Cheng G; Zou M; Sun J; Cui F
    Pharmazie; 2004 Sep; 59(9):709-12. PubMed ID: 15497754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and passive target of 5-fluorouracil solid lipid nanoparticles.
    Du B; Yan Y; Li Y; Wang S; Zhang Z
    Pharm Dev Technol; 2010; 15(4):346-53. PubMed ID: 19769532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice.
    Jin Y; Li J; Rong LF; Lü XW; Huang Y; Xu SY
    Acta Pharmacol Sin; 2005 Feb; 26(2):250-6. PubMed ID: 15663907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics and distribution of 5-Fu magnetic albumin deuto-microsphere in normal and tumor-bearing mice].
    Xu R; Shi SJ; Zhou SC; Zheng JW; Chen H; Zou SQ; Zeng FD
    Yao Xue Xue Bao; 2007 Jan; 42(1):66-70. PubMed ID: 17520810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits.
    Pohlen U; Reszka R; Schneider P; Buhr HJ; Berger G
    Anticancer Res; 2004; 24(3a):1699-704. PubMed ID: 15274343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.
    Bocci G; Barbara C; Vannozzi F; Di Paolo A; Melosi A; Barsanti G; Allegrini G; Falcone A; Del Tacca M; Danesi R
    Clin Pharmacol Ther; 2006 Oct; 80(4):384-95. PubMed ID: 17015056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites.
    Wang GP; Guan YS; Jin XR; Jiang SS; Lu ZJ; Wu Y; Li Y; Li M; Luo F
    J Gastroenterol Hepatol; 2010 May; 25(5):985-90. PubMed ID: 20546454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
    Chandrashekar NS; Shobha Rani RH
    J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study.
    Menei P; Venier MC; Gamelin E; Saint-André JP; Hayek G; Jadaud E; Fournier D; Mercier P; Guy G; Benoit JP
    Cancer; 1999 Jul; 86(2):325-30. PubMed ID: 10421269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting.
    Lai LF; Guo HX
    Int J Pharm; 2011 Feb; 404(1-2):317-23. PubMed ID: 21094232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts.
    Smith JP; Kanekal S; Patawaran MB; Chen JY; Jones RE; Orenberg EK; Yu NY
    Cancer Chemother Pharmacol; 1999; 44(4):267-74. PubMed ID: 10447573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug distribution in gastric cancer and adjacent tissues by preoperative intraperitoneal chemotherapy with Co-fluorouracil liposome].
    Li Y; Liu BW; DU WL; Song ZC; Zhao Q; Fan LQ; Yang JQ; Li QJ; Wang MX; Jiao ZK; Zhang ZD
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):638-40. PubMed ID: 15634532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transnasal delivery of 5-fluorouracil to the brain in the rat.
    Sakane T; Yamashita S; Yata N; Sezaki H
    J Drug Target; 1999; 7(3):233-40. PubMed ID: 10680979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release kinetics of 5-fluorouracil-loaded microspheres on an experimental rat glioma.
    Roullin VG; Lemaire L; Venier-Julienne MC; Faisant N; Franconi F; Benoit JP
    Anticancer Res; 2003; 23(1A):21-5. PubMed ID: 12680190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasonically controlled release and targeted delivery of diclofenac sodium via gelatin magnetic microspheres.
    Saravanan M; Bhaskar K; Maharajan G; Pillai KS
    Int J Pharm; 2004 Sep; 283(1-2):71-82. PubMed ID: 15363503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.
    Muvaffak A; Gurhan I; Gunduz U; Hasirci N
    J Drug Target; 2005 Apr; 13(3):151-9. PubMed ID: 16036303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microemulsion-based gel of fluorouracil for transdermal delivery].
    Xiao YY; Liu F; Chen ZP; Ping QN
    Yao Xue Xue Bao; 2010 Nov; 45(11):1440-6. PubMed ID: 21361046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer.
    Ahmad MZ; Akhter S; Anwar M; Ahmad FJ
    Mol Pharm; 2012 Nov; 9(11):2986-94. PubMed ID: 22994847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ofloxacin targeting to lungs by way of microspheres.
    Harsha S; R C; Rani S
    Int J Pharm; 2009 Oct; 380(1-2):127-32. PubMed ID: 19646516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
    Zheng JL; Liang LJ; Hu WJ; Shen SL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.